Merck & Co. Inc. (MRK) |
|
84.55 -0.27 (-0.32%)
|
11-14 16:02 |
|
Open: |
84.92 |
Pre. Close: |
84.82 |
|
High:
|
85.18 |
Low:
|
83.7 |
|
Volume:
|
7,222,570 |
Market Cap:
|
217054M |
|
|
|
|
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
85.28 - 85.729 |
85.729 - 86.111 |
|
Low:
|
82.629 - 83.141 |
83.141 - 83.577 |
|
Close:
|
83.707 - 84.578 |
84.578 - 85.319 |
|
Technical analysis |
as of: 2019-11-14 4:31:18 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time. |
| Target: |
Six months: 101.90 One year: 119.01 |
| Support: |
Support1: 82.92 Support2: 80.25 |
| Resistance: |
Resistance1: 87.24 Resistance2: 101.90 |
| Pivot: |
84.05  |
| Moving Average: |
MA(5): 84.07 MA(20): 83.83
MA(100): 83.94 MA(250): 80.74 |
| MACD: |
MACD(12,26): 0.07 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 60.24 %D(3): 54.41 |
| RSI: |
RSI(14): 52.86 |
| 52-week: |
High: 87.35 Low: 70.89 Change(%): 13.0 |
| Average Vol(K): |
3-Month: 811034 10-Days: 765591 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.MRK has closed below upper band by 40.2%. Bollinger Bands are 4.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 15 Nov 2019 10:42:35 +0000
What's Bristol-Myers Squibb's Fair Stock Price Estimate Based On Expected 2019 Earnings?
Thu, 14 Nov 2019 07:33:28 +0000
AZN:FDA Accepts Regulatory Submission For Selumetinib In Neurofibromatosis Type1
Thu, 31 Oct 2019 04:09:08 +0000
Despite Key Patent Losses Roche Could Add $5 Billion In Sales Over The Next 3 Years
Tue, 12 Nov 2019 08:57:14 +0000
Roche's New Oncology Drugs To Add $5 Billion In Sales By 2021?
Wed, 13 Nov 2019 15:49:00 +0000
Noteworthy ETF Outflows: IYH, MRK, PFE, ABBV
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2550.00 |
| Shares Float (M) |
2540.00 |
|
% Held by Insiders
|
0.08 |
|
% Held by Institutions
|
78.28 |
|
Shares Short (K)
|
17980 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
3.580 |
|
Book Value (p.s.)
|
10.520 |
|
PEG Ratio
|
1.69 |
|
Profit Margin
|
20.26 |
|
Operating Margin
|
31.60 |
|
Return on Assets (ttm)
|
10.8 |
|
Return on Equity (ttm)
|
30.9 |
|
Qtrly Rev. Growth
|
14.9 |
|
Gross Profit (p.s.)
|
11.298 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
7.090 |
|
Qtrly Earnings Growth
|
-2.50 |
|
Operating Cash Flow (M)
|
12240.00 |
|
Levered Free Cash Flow (M)
|
9740.00 |
Stock Valuations |
|
P/E
|
23.62 |
|
P/E Growth Ratio
|
|
|
P/BV
|
8.04 |
|
P/S
|
4.75 |
|
P/CF
|
17.61 |
Dividends & Splits |
|
Dividend
|
2.130 |
|
Dividend Yield
|
0.03 |
|
Dividend Pay Date
|
2019-10-07 |
|
Ex-Dividend Date
|
2019-09-13 |
|
Forward Dividend
|
2.200 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
